Substance P activates the release of histamine from human skin mast cells through a pertussis toxin-sensitive and protein kinase C-dependent mechanism

Clinical Immunology and Immunopathology

Volumn 81, Issue 1, 1996, Pages 68-73

  Columbo, Michele ^a   Horowitz, Edward M ^a   Kagey Sobotka, Anne ^a   Lichtenstein, Lawrence M ^a  

^a JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRYOSTATIN 1; CYCLIC AMP; GENISTEIN; HISTAMINE; IMMUNOGLOBULIN E ANTIBODY; PERTUSSIS TOXIN; PROTEIN G; PROTEIN KINASE C; SUBSTANCE P;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MAST CELL; PRIORITY JOURNAL; SKIN ALLERGY; SKIN CELL;

EID: 0030271364     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.0159     Document Type: Article

References (36)

1. 1. Metcalfe, D. D., Costa, J. J., and Burd, P. R., Mast cells and basophils. In "Inflammation: Basic Principles and Clinical Correlates" (J. I. Gallin, I. M. Goldstein, and R. Snyderman, Eds.), pp. 709-725. Raven Press, New York, 1992.
2. 2. Marone, G., In vitro and in vivo modulation of human mast cells and basophils. In "Asthma: Physiology and Treatment" (S. T. Holgate et al., Eds.), pp. 419-434. Academic Press, New York, 1993.
3. 3. Lawrence, I. D., Warner, J. A., Cohan, V. L., Hubbard, W. C., Kagey-Sobotka, A., and Lichtenstein, L. M., Purification and characterization of human skin mast cells. Evidence for human mast cell heterogeneity. J. Immunol. 139, 3062-3069, 1987.
4. 4. Patella, V., Marinò, I., Lamparter, B., Arbustini, E., Adt, M., and Marone, G., Human heart mast cells. Isolation, purification, ultrastructure, and immunologic characterization. J. Immunol. 154, 2855-2865, 1995.
5. 5. de Paulis, A., Marinò, I., Ciccarelli, A., De Crescenzo, G., Concardi, M., Verga, L., Arbustini, E., and Marone, G., Human synovial mast cells. I. Ultrastructure in situ and in vitro immunologic characterization. Arth. Rheum., in press, 1996.
6. 6. Benyon, R. C., The human skin mast cell. Clin. Exp. Allergy 19, 375-387, 1989.
7. 7. Walsh, L. J., Trinchieri, G., Waldorf, H. A., Whitaker, D., and Murphy, G. F., Human dermal mast cells contain and release tumor necrosis factor α, which induces endothelial leukocyte adhesion molecule 1. Proc. Natl. Acad. Sci. USA 88, 4220-4224, 1989.
8. 8. McLeod, J., Hayes, N. A., and Foreman, J. C., Effect of 12-O-tetradecanoylphorbol-13-acetate (TPA) on substance P-induced histamine release from rat peritoneal mast cells. Agents Actions 30, 140-142, 1990.
9. 9. Mio, M., Izushi, K., and Tasaka, K., Substance P-induced histamine release from rat peritoneal mast cells and its inhibition by antiallergic agents and calmodulin inhibitors. Immunopharmacology 22, 59-66, 1991.
10. 2 inhibitor ONO-RS-082 on substance P-induced histamine release from rat peritoneal mast cells. Int. Arch. Allergy Immunol. 97, 226-228, 1992.
11. 11. Church, M. K., El-Lati, S., and Caulfield, J. P., Neuropeptide-induced secretion from human skin mast cells. Int. Arch. Allergy Appl. Immunol. 94, 310-318, 1991.
12. 2+ levels in human adult skin mast cells activated by the ligand for the human c-kit receptor and anti-IgE. Biochem. Pharmacol. 47, 2137-2145, 1994.
13. 13. Adkinson, N. F., Jr., Measurement of total serum immunoglobulin E and allergen-specific immunoglobulin E antibody. In "Manual of Clinical Immunology" (N. R. Rose and H. Friedman, Eds.), pp. 800-807, The American Society of Microbiology, Washington, 1980.
14. 14. Gilbert, H. S., and Ornstein, L., Basophil counting with a new staining method using Alcian blue. Blood 46, 279-286, 1975.
15. 15. Siraganian, R. P., An automated continuous-flow system for the extraction and fluorometric analysis of histamine. Anal. Biochem. 57, 383-394, 1974.
16. 16. Schulman, E. S., MacGlashan, D. W., Jr., Peters, S. P., Schleimer, R. P., Newball, H. H., and Lichtenstein, L. M., Human lung mast cells: Purification and characterization. J. Immunol. 129, 2662-2667, 1982.
17. 17. Garret, C., Carruette, A., Fardin, V., Moussaoui, S., Peyronel, J-F., Blanchard, J-C., and Laduron, P. M., Pharmacological properties of a potent and selective nonpeptide substance P antagonist. Proc. Natl. Acad. Sci. USA 88, 10208-10212, 1991.
18. 18. Clapham, D. E., and Neer, E. J., New roles for G-protein βγ-dimers in transmembrane signalling. Nature 365, 403-406, 1993.
19. 19. Lichtenstein, L. M., and Margolis, S. M., Histamine release in vitro: Inhibition by catecholamines and methylxanthines. Science 161, 902-903, 1968.
20. 20. Peachell, P. T., MacGlashan, D. W., Jr., Lichtenstein, L. M., and Schleimer, R. P., Regulation of human basophil and lung mast cell function by cyclic adenosine monophosphate. J. Immunol. 140, 571-579, 1988.
21. 21. Peachell, P. T., Undem, B. J., Schleimer, R. P., MacGlashan, D. W., Jr., Cieslinski, L. B., and Torphy, T. J., Preliminary identification and role of phosphodiesterase isozymes in human basophils. J. Immunol. 148, 2503-2510, 1992.
22. 22. Hess, A. D., Silanskis, M. K., Esa, A. H., Pettit, G. R., and May, W. S., Activation of human T-lymphocytes by bryostatin. J. Immunol. 141, 3263-3269, 1988.
23. 23. Patella, V., Casolaro, V., Ciccarelli, A., Pettit, G. R., Columbo, M., and Marone, G., The antineoplastic bryostatins affect human basophils and mast cells differently. Blood 85, 1272-1281, 1995.
24. 24. Massey, W. A., Cohan, V. L., MacGlashan, D. W., Jr., Gittlen, S. W., Kagey-Sobotka, A., Lichtenstein, L. M., and Warner, J. A., Protein kinase C modulates immunoglobulin E-mediated activation of human mast cells from lung and skin. I. Pharmacologic inhibition. J. Pharacol. Exp. Ther. 258, 824-829, 1991.
25. 25. Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, S., Itoh, N., Shibuya, M., and Fukami, Y., Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262, 5592-5595, 1987.
26. t on phospholipid methylation and histamine release in mast cells activated by concanavalin A, anti-IgE and antigen. J. Biochem. 105, 219-225, 1989.
27. 27. Markwardt, F., Hoffmann, J., and Korbs, E., The influence of synthetic thrombin inhibitors on the thrombin-antithrombin reaction. Thromb. Res. 2, 343-348, 1973.
28. 1) receptor. Science 251, 435-437, 1991.
29. 29. Repke, H., and Bienert, M., Mast cell activation - a receptor-independent mode of substance P action? FEBS Lett. 221, 236-240, 1987.
30. 30. Lowman, M. A., Benyon, R. C., and Church, M. K., Characterization of neuropeptide-induced histamine release from human dispersed skin mast cells. Br. J. Pharmacol. 95, 121-130, 1988.
31. 31. Churcher, Y., Kramer, I. M., and Gomperts, B. D., Evidence for protein dephosphorylation as a permissive step in GTP-γ-S-induced exocytosis from permeabilized mast cells. Cell Regul. 1, 523-530, 1990.
32. 32. Bueb, J. L., Mousli, M., Landry, Y., and Bronner, C., A pertussis toxin-sensitive G protein is required to induce histamine release from rat peritoneal mast cells by bradykinin. Agents Actions 30, 98-101, 1990.
33. 33. von zur Muhlen, F., Eckstein, F., and Penner, R., Guanosine 5′-[β-thio]triphosphate selectively activates calcium signaling in mast cells. Proc. Natl. Acad. Sci USA 88, 926-930, 1991.
34. 34. Morishima, Y., Nakata, Y., and Segawa, T., Comparison of the effects of ions and GTP on substance P binding to membrane-bound and solubilized specific sites. J. Neurochem. 53, 1428-1434, 1989.
35. 35. Kolasinski, S. L., Haines, K. A., Siegel, E. L., Cronstein, B. N., Abramson, S. B., Neuropeptides and inflammation. A somatostatin analog as a selective antagonist of neutrophil activation by substance P. Arth. Rheum. 35, 369-375, 1992.
36. 36. Church, M. K., Lowman, M. A., Robinson, C., Holgate, S. T., and Benyon, R. C., Interaction of neuropeptides with human mast cells. Int. Arch. Allergy Appl. Immunol. 88, 70-78, 1989.